Cost-Effectiveness And Cost-Utility Analysis Of Belimumab For The Treatment Of Patients With Systemic Lupus Erythematosus In Portugal
AuthID
P-00P-84Y
P-00P-84Y
© 2024 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service